Navigation Links
Uroplasty Reports Third Quarter Fiscal 2009 Results
Date:2/3/2009

ducts that treat urinary incontinence. In addition, the January 2009 issue of the Journal of Urology highlighted results from a clinical study of Macroplastique. The study concluded that in the Macroplastique patient group, the dry/cure rate was 36.9% versus 24.8% in the control patient group. The authors of the study concluded that Macroplastique is a safe, effective, minimally invasive material that can be administered on an outpatient basis. The combination of these factors resulted in record sales for Macroplastique in our fiscal third quarter," concluded Mr. Kaysen.

Fiscal Third Quarter and Nine Month Results for the Periods Ended December 31, 2008

Net sales for the three months ended December 31, 2008 were $3.4 million versus $3.7 million for the same period a year ago. Net sales for the nine months ended December 31, 2008 were $11.8 million, up 22% from $9.7 million for the same period a year ago.

Sales to customers in the U.S. for the three months ended December 31, 2008 were $1.9 million, down one percent, compared with $2.0 million in the same period a year ago. This decrease was due to the reimbursement uncertainty that has developed in the U.S. market for Urgent PC treatments. Sales to customers outside of the U.S. for the three months ended December 31, 2008 were $1.4 million, down 18% from $1.8 million in the year ago period. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales to customers outside of the U.S. declined approximately 5%.

Nine month sales to customers in the U.S. were $6.4 million, an increase of 52% from $4.2 million for the same period last year. Nine month sales to customers outside of the U.S. were flat at $5.5 million as compared with the same period last year. Excluding the translation impact of fluctuations in foreign currency exchange rates, sales to customers outside of the U.S. declined approximately 2%
'/>"/>

SOURCE Uroplasty, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Uroplasty to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York
2. Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31, 2007
3. Uroplasty to Host Third Quarter Conference Call on February 11
4. Neurobiological Technologies Reports Receipt of $1.5 Million Royalty Payment for Quarterly Sales of Memantine
5. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
6. Recent Reports Regarding Mercury and High Fructose Corn Syrup Flawed and Misleading
7. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
8. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
9. CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009
10. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
11. Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company") ... today announces that application has been sought for 530,000 new ... admitted to trading on AIM. The new Ordinary Shares are ... Philip Haworth, former Chief Executive Officer of Silence. ...
... WEST LAFAYETTE, Ind. ╨ Engineers have discovered details about ... new applications in manufacturing, diagnostics and other research., ... create features and surface textures in metals, ceramics and other ... biosensors. The lasers pulse at durations of 100 femtoseconds, or ...
... CAMBRIDGE, Mass., Dec. 19, 2011 Access Industries ... a new life sciences venture investment initiative to ... team,s experience in startup creation, technology commercialization and ... and also create de-novo spinoffs around potential high-impact ...
Cached Biology Technology:Silence Therapeutics Additional Listing 2Silence Therapeutics Additional Listing 3Research could improve laser-manufacturing technique 2Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities 2Access BridgeGap Ventures to Focus on Early-Stage Therapeutic Opportunities 3
(Date:4/15/2014)... of Arts and Sciences (KNAW) has announced the names ... prestigious Heineken Prizes (one million US dollars prize money ... their great merits to science. , This year marks ... to the Austrian-American chemist Erwin Chargaff in 1964. , ... to the following laureates: , Christopher M. ...
(Date:4/15/2014)... soon could be powering the forklifts used in warehouses ... faster refueling times than ever before, courtesy of a ... (HHC). , The goal of the project is to ... at low pressure four to five times faster than ... a competitive advantage over batteries for a big slice ...
(Date:4/14/2014)... to unravel the molecular changes that underlie one of ... When the bacterium Yersinia pestis enters the lungs, it ... fatal if untreated. The way in which Y. ... in a matter of days has largely confounded scientists, ... the presence of a protein called the plasminogen activator ...
Breaking Biology News(10 mins):Five scientists awarded prestigious Heineken Prizes 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 2Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 3Low-cost, hydrogen-powered forklifts with rapid refueling, zero emissions coming soon 4Plague alters cell death to kill host 2
... Iceland,s Eyjafjallajoekull volcano have produced a 1600 km-wide ash ... and then south, is clearly visible in stark contrast ... May. The volcano began emitting steam and ash ... month. Renewed activity earlier this week caused some flights ...
... Assistant Professor Carla Finkielstein has been presented with a ... by the American Association for Cancer Research (AACR), is ... researchers and increase the recognition of minorities involved in ... in the Department of Biological Sciences in the College ...
... a leading scientist at the Office of Naval Research, discussed ... and wastewater during National Public Radio,s recent "Science Friday" segment. ... of the microbial fuel cell to power different types of ... program officer for ONR,s Naval Biosciences and Biocentric Technology Program. ...
Cached Biology News:Biologist Carla Finkielstein receives Minority Scholar Award 2ONR scientist generates 'mud power' for NPR radio audience 2
... 1;heading 2;Many mammalian ... experimental situations create ... transfection and other ... ViraPower Lentiviral Expression ...
... Product Rabbit polyclonal to ... conjugated to KLH, corresponding to amino ... / Specificity Cross-reacts with Rat.Expected to ... Mouse (100% identity with immunogen), Rabbit (100% ...
RayBio Human Angiogenesis Antibody Array 2.1 (8 array membranes) with Accessory, detects 23 angiogenic factors (for lysate) Class: Antibody Array Products Product Group: Antibody Array...
... Cryo/CryoPlus Inventory Racks for ... available with cardboard or stainless ... or 5ml cryo vials. ... racks available. Platform risers ...
Biology Products: